GREENLEAF LABS CORP – Trademark Portfolio

Entity Type: 03

GREENLEAF LABS CORP holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include TWINLEAF, GREENFORD, and TIGERCRAFT. The owner is based in CASPER, WY.

312 W 2ND ST PMB 5010

CASPER, WY 82601

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GREENLEAF LABS CORP's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GREENLEAF LABS CORP have?

GREENLEAF LABS CORP has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does GREENLEAF LABS CORP file in?

GREENLEAF LABS CORP files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GREENLEAF LABS CORP's most well-known trademarks?

GREENLEAF LABS CORP's registered trademark portfolio includes well-known marks such as TWINLEAF, GREENFORD, and TIGERCRAFT. These are among 4 currently registered trademarks in the portfolio.

What is GREENLEAF LABS CORP's trademark registration success rate?

GREENLEAF LABS CORP has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.